Mizuho Securities analyst Graig Suvannavejh has maintained their bullish stance on AXSM stock, giving a Buy rating on January 24. Graig Suvannavejh has given his Buy rating due to a combination of ...

The Zoryve franchise, particularly its topical treatments, has shown robust prescription growth. Notably, the total prescriptions (TRxs) for Zoryve Cream 0.15% and Zoryve Foam 0.3% have ...

Our expert, award-winning staff selects the products we cover and rigorously researches and tests our top picks. If you buy through our links, we may get a commission. Executive Editor David ...

Click the FOLLOW button to be the first to know about this artist's upcoming lots, sold lots, exhibitions and articles ...

When building a strong brand identity, your logo is the star of the show. It’s often the first thing customers see, recognize ...